Deep Targeted Sequencing Reveals the Diversity of TRB-CDR3 Repertoire in Patients with Preeclampsia.

Changlong Guo,Ruikun Cai,Xiaofang Cao,Ying Yang,Qidi Wang,Runsheng He,Lisha An,Zuoqi Peng,Yequn Chen,Shuhua Ni,Xuerui Tan,Jian Han,Xin Liu,Li Lin,Song Yu,Xingyu Wang,Chunlin Wang,Xu Ma
DOI: https://doi.org/10.1016/j.humimm.2019.04.003
IF: 2.211
2019-01-01
Human Immunology
Abstract:Preeclampsia (PE) is one of the major causes of maternal and perinatal mortality worldwide. This study aimed to determine the immunological characteristics of PE patients and normal pregnancy at the T cell receptor beta-chain (TRB) level by using high-throughput sequencing. High-throughput sequencing was performed to analyze the expression of TRB-CDR3 in circulating T cells. T cells were isolated from 36 healthy pregnant women, 24 patients with severe PE, and 18 patients with moderate PE. Rearranged mRNA sequences were assigned to their germline V, D, and J counterparts, and translated into proper amino acids by the IMGT database. In general, PE samples had more TRB-CDR3 reads and types than those of normal pregnant woman in the circulation, but the mean number of TRB-CDR3 reads and unique TRB-CDR3 reads in severe group was lower than that in the moderate group. In PE patients, the V7_9 and V20_1 gene loci were more prevalent than in healthy pregnant women. In addition, 4 kinds of TRB-CDR3 peptides were found to be highly relevant to the pathogenesis of PE. Of them, peptides matched to herpes simplex virus antigen-specific T cells were much lower in PE samples.
What problem does this paper attempt to address?